| Date | Title | Description |
| 18.08.2026 | Abcuro Raises $66M in Series D Funding | Abcuro, a Newton, MA-based clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases through precise modulation of cytotoxic T cells, raised $66M in Series D funding.
The round was led by New Leaf Ve... |
| 23.10.2023 | Which VCs are investing in rare diseases? | Firms include Chiesi Ventures, Frazier Healthcare Partners, OrbiMed, and Atlas Venture
In the United States alone 25 million people suffer from rare disease, a number that jumps to 400 million people globally. While 1 in 10 people will suff... |
| 19.08.2022 | Medication Intelligence Startup Arine Raises $29M
| What You Should Know: |
| 14.07.2021 | Saniona : secures SEK 87 million ($10 million) non-dilutive term loan | PRESS RELEASE
July 14, 2021
Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has entered into a non-dilutive term loan agreement for SEK 87 million ($10 million) with Formue... |
| 21.06.2021 | Cleerly Launches with $43M for Digital Care Pathway Solution for Heart Attack Prevention | What You Should Know:
– Cleerly, a New York City-based company launched today with $43M in Series B funding and unveiled its first-of-its-kind digital care pathway solution for heart attack prevention. The Series B funding, which was led by... |
| 24.06.2020 | BrightInsight raises $40M to build a digital platform for medtech and biopharma | The company will use the new funding, in part, to expand to Europe and Asia
While the healthtech space in general is becoming increasingly digitized, the same cannot be said for the life sciences and medtech spaces. Part of the reason for t... |
| 23.06.2020 | BrightInsight Raises $40M for Regulated Digital Health Platform for Biopharma & Medtech | What You Should Know:
– BrightInsight, provider of the leading global regulated digital health platform for biopharma and medtech, today announced a Series B funding round of $40 million, led by global venture capital and private equity fir... |
| 22.06.2020 | SANIONA AB (PUBL)
Saniona raises SEK 22 million through sales of shares in Scandion Oncology | PRESS RELEASE
22 June, 2020
Saniona (OMX: SANION), a clinical-stage biotech company focused on rare diseases, today announced that it has raised SEK 22 million (USD 2.3 million) through the sale of shares in Scandion Oncology A/S (Spotlight... |
| 17.09.2019 | Boulder’s Edgewise Therapeutics closes $50 million Series B financing | Edgewise Therapeutics, a Boulder company working to develop new therapies for treating patients with debilitating musculoskeletal disease, announced the closing of a $50 million Series B financing round on Tuesday.
The funding will help the... |
| 05.09.2019 | BrightInsight Nabs $25M for Regulated IoT Platform for Biopharma and Medtech | – BrightInsight raises $25M in Series A funding co-led by New Leaf Venture Partners and Eclipse Ventures to further enhance the functionality of its BrightInsight Platform and accelerate global commercialization efforts.
– BrightInsight pla... |
| 01.08.2018 | New Leaf Venture Leads $55M Series B for ReViral | LONDON--(BUSINESS WIRE)--ReViral, an antiviral drug discovery and development company, focused on diseases caused by the Respiratory Syncytial Virus (RSV), today announced the successful completion of a US$55 million Series B financing.
The... |
| 01.08.2018 | New Leaf Venture Leads $55M Series B for ReViral | LONDON--(BUSINESS WIRE)--ReViral, an antiviral drug discovery and development company, focused on diseases caused by the Respiratory Syncytial Virus (RSV), today announced the successful completion of a US$55 million Series B financing.
The... |
| 01.02.2018 | Every New York City Venture Firm, Listed | As entrepreneurs brush off their pitch decks for the new year, they'll likely realize that finding the right venture fund is tougher than ever. Even though last year's VC deal dollars added up to the largest amount since the dot com boom, t... |
| 25.05.2017 | New Leaf Venture Partners Leads $45M Series B for Harpoon Therapeutics | Harpoon Therapeutics said it raised $45 million of Series B financing in a deal co-led by Arix Bioscience and New Leaf Venture Partners and joined by new investor Taiho Ventures and existing investor MPM Capital.
Arix Investment Manager Mar... |
| 25.05.2017 | New Leaf Venture Partners Leads $45M Series B for Harpoon Therapeutics | Harpoon Therapeutics said it raised $45 million of Series B financing in a deal co-led by Arix Bioscience and New Leaf Venture Partners and joined by new investor Taiho Ventures and existing investor MPM Capital.
Arix Investment Manager Mar... |
| 27.06.2016 | CRISPR Therapeutics Raises Additional $38M | |
| 26.06.2016 | New Leaf Venture Partners Joins $38M Series B for Crispr Therapeutics | BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CRISPR Therapeutics, a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines, announced an additional $38 million closi... |
| 20.06.2016 | Drug tracking tech developer Kit Check raises $15M in Series C round (Updated) | Baxter Ventures led the round, and new investor Black Granite Capital also participated. Returning investors that took part in the round included Kaiser Permanente Ventures, Rex Health Ventures, New Leaf Venture Partners, Easton Capital Inv... |
| 20.06.2016 | New Leaf Venture Joins $15M Series C for Kit Check | Kit Check™ (https://kitcheck.com), the leader in hospital pharmacy medication tracking and restocking automation software, announced a $15 million Series C funding round led by Baxter Ventures, the venture investment arm of Baxter Internati... |
| 26.05.2016 | Kaiser Permanente Ventures senior managing director talks about his return (Q&A) | Sam Brasch has moved back to Kaiser Permanente Ventures, the investment arm of the Kaiser Permanente health system, this time as senior managing director. The move comes after a year of working with New Leaf Venture Partners, which invests ... |
| 24.03.2016 | Daily funding roundup - March 24, 2016 | Mesophere received $73.5M investment; Iterum Therapeutics secured $40M; Lagou completed Series C
Malaysia-based Nuren Group, a company that runs a number of women-dedicated content and e-commerce websites, raised $2 million in a Series A ro... |
| 12.01.2016 | Using facial recognition and AI to confirm medication adherence, AiCure raises $12.25M | The developers of AiCure’s technology have likened it to a personal trainer in a gym working directly with a client to achieve their goals. It involves facial recognition and motion-sensors in a mobile device. It records patients taking the... |
| 03.12.2015 | Daily funding roundup - Dec. 3, 2015 | True North Therapeutics bagged $40M; Allocadia raised $16.5M; Younity received $8M funding
Younity, an iOS app for streaming media from your Mac, today announced an $8 million Series A round of funding led by venture capital firm Marker LLC... |
| 21.10.2015 | Daily funding roundup - October 21, 2015` | Arvinas bagged $41.6M; Clavis Insight received $20M; Adjust landed $17M
LeanTaaS, a Silicon Valley healthcare SaaS provider, today announced its first institutional funding round of $3 million led by Sedgwick Claims Management Services, Inc... |
| 21.09.2015 | Deciphera raises $75M directed toward kinase-inhibiting cancer drug | Taylor aims to eventually put together a broad syndicate of crossover investors that can support an IPO, but the $75 million, which should fund Deciphera through 2017, gives the company some time to decide when. It’ll gather clinical data o... |
| 21.09.2015 | Daily funding roundup - September 21, 2015 | Deciphera bagged $75M; Portea raised $37.5M; Just Biotherapeutics secured $15M
BidFlyer, an Israeli startup that is a white-label platform for airlines, has raised $1 million in funding for its business model, which involves putting small b... |
| 17.09.2015 | Daily funding roundup - September 17, 2015 | HelloFresh raised $85M; Kyruus landed $25M; Typeform secured $15M
Advizr, a highly intuitive and automated financial planning application for advisors serving Gen X and Y clients, announces the close of another financing round and adds indu... |
| 12.01.2015 | Kit Check raises $12M to boost hospital drug security tech in pharmacy, OR | Kaiser Permanente Ventures led the round, which also included Rex Health Ventures, the venture investment arm of Rex Healthcare in Raleigh, North Carolina. Investors that participated in the Series A in 2o13 returned too, including New Leaf... |
| 06.05.2014 | QPID Health Raises $12.3M in Series B Funding | QPID Health, a Boston, MA-based developer of clinical intelligence solutions for healthcare providers, raised $12.3m in Series B funding.
The round, which followed a $4.4m Series A round (read here), was led by New York City-based New Leaf ... |
| 06.05.2014 | QPID Health Raises $12.3M in Series B to Help Clinicians Manage Patient Records Smarter | Electronic health records startup QPID Health just landed $12.3 million in Series B funding led by New Leaf Venture Partners, with participation from existing investors Cardinal Partners and Matrix Partners, among others. QPID Health also w... |
| 06.05.2014 | QPID Health Series B rakes in $12.3 million for surgery risk assessment platform | It is also looking to develop collaborations with University of Pittsburgh Medical Center, Johns Hopkins Hospital, Geisinger Health, Cleveland Clinic and Mayo Clinic.
Today’s investment enables QPID to accelerate the growth of the company a... |
| 27.01.2014 | Buoyed by mobile health trends, TigerText raises $21M in Series B round | Co-founder and CEO Brad Brooks outlined a few examples of how the API is being used. Pathology Inc., a women’s health lab, is using it to send lab alerts to its physician customers. A partnership with Ontario-based PointClickCare helped exp... |
| 22.01.2014 | It looks like UnitedHealth is acquiring Audax Health Solutions | In its latest report tracking payers’ priorities, Chilmark Research points out that projects are targeting member engagement. It is also seeing a growing investment in payer-owned consumer platforms, biometric tracking and new social media ... |
| 11.11.2013 | Just a little overweight? Medtech company creates nonsurgical obesity treatment for weight loss | Once the device is drained, deflated and removed, the patient continues the therapy portion of the treatment for an additional six months. The idea is the balloon jump-starts the patient into behaviors everyone already recognizes are health... |
| 28.08.2013 | Digital health group with patient engagement focus attracts funding from Florida insurer, Facebook VP | To date, it’s raised $55 million from backers that include New Leaf Ventures, Cardinal Health and insurer Cigna. Earlier this year, Cigna CIO Mark Boxer joined its board. At the time he said one advantage of the company was its ability to u... |
| 16.07.2013 | New Leaf Venture Partners leads $10.4M Series A for RFID tagging startup Kit Check | After they’re used, these kits are traditionally manually inspected by pharmacy technicians, who check the expiration dates on all of the drugs left inside and replenish the ones that have been used. Then the technicians hand the kits off t... |
| 24.04.2013 | Treato Secures $14.5M in Funding | Treato, a Yehud, Israel-based provider of social health patient intelligence solutions, secured $14.5m in funding.
The round was led by OrbiMed Israel Partners and New Leaf Venture Partners, with participation from existing investors Reed E... |
| 10.04.2013 | iRhythm raises $16M for patch that stores heartbeat data to help spot arrhythmia | When it’s time to take off the patch, patients send it to iRhythm’s national clinical center for processing. The data is assembled into reports that are made available to physicians, but patients also get access to them.
The U.S. Food and D... |
| 15.11.2012 | California pharma start-up targeting COPD & asthma using inhalers raises $65M | The money will be used to start a Phase 3 clinical trial for PT003, the company’s lead candidate to treat COPD.
“Through our comprehensive Phase 2 program, Pearl has characterized the dose response, minimally effective dose and optimal dose... |
| 13.11.2012 | Pearl Therapeutics Raises $65M in Series D Financing | Pearl Therapeutics Inc., a Redwood City, CA-based biopharmaceuticals company, has raised $65m in Series D financing.
The round was led by Vatera Healthcare Partners, with participation from existing investors 5AM Ventures, Clarus Ventures a... |
| 01.11.2012 | Advanced Cell Diagnostics Raises $12M in Series B Financing | Advanced Cell Diagnostics Inc. (ACD), a Hayward, CA-based life science research and clinical diagnostics company, has raised $12m in Series B financing.
Backers include New Leaf Venture Partners and Morningside Ventures.
The company intends... |
| 25.10.2012 | VC prediction: 2013 will be a good year for medtech deals | Adele Olivia of Quaker Partners was also optimistic and said the quality and opportunity of deals is unprecedented.
“I just can’t believe the quality of teams we are seeing, and the state of assets,” she said. “This is a great time to be in... |
| 28.09.2012 | IlluminOss Medical Secures $28M in Series C Venture Capital Financing | IlluminOss Medical, Inc., a East Providence, RI-based developer of photodynamic orthopedic implants, has secured $28m in Series C venture capital financing.
The round was co-led by Tekla Capital Management and Life Sciences Partners, with p... |
| 25.07.2012 | Fundraising: Abdominal aortic aneurysm repair company raises $6 million | Location: San Clemente, California.
Product: Abdominal Aortic Aneurysm Stent-Graft to repair abdominal aortic aneurysms.
Money raised: $6 million (earlier regulatory filings show the company raised an additional $16.5 million).
How it will ... |
| 27.04.2012 | New York health IT accelerator is looking for applicants | Hospitals and healthcare systems tend to be very cautious about working with external vendors on health IT applications, which can make it a bit of a challenge for companies to get an audience with providers, let alone convincing them to ad... |
| 02.04.2012 | Former head of Sanofi vaccines division becomes infectious disease biotech CEO | Last year, it was granted a five-year research grant valued up to $196 million by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to fund the development of seasonal and ... |
| 01.09.2011 | Pfizer extends Icagen offer; remains just shy of shares needed for deal | The agreement for a Pfizer acquisition of Icagen was announced on July 20, a cash deal valued at $6 per share. That price was a more than 22 percent discount to the July 19 close of $7.75. Icagen shares traded at around $2.40 per share unti... |
| 12.08.2011 | Investors blocking PFE’s $56M ICGN bid say firm’s value could be $165M | Two Icagen (NASDAQ:ICGN) institutional investors opposed to Pfizer‘s (NYSE:PFE) $56 million offer for the pain drug development company now say the company’s value should be nearly three times that amount.
Merlin Nexus and New Leaf Venture ... |
| 29.07.2011 | Pfizer-Icagen deal faces problem: Merlin Nexus opposes price | Pfizer’s (NYSE:PFE) $56 million bid to acquire Icagen (NASDAQ:ICGN) faces a big hurdle — two of Icagen’s largest shareholders.
Merlin Nexus and New Leaf Venture Partners, two firms holding Icagen stock, submitted a July 28 letter to the Ica... |
| 14.02.2011 | Antiviral pharma Chimerix raises $45M in series F venture round | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 19.10.2010 | Pearl Therapeutics Closes $69M Series C Financing | Pearl Therapeutics Inc., a Redwood City, CA-based company that develops clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COP... |
| 25.06.2009 | Spiracur takes $20.3M for effective wound healing | Spiracur, developer of a device used to heal small wounds effectively, has brought in $20.3 million in a second round of funding from Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures, reports VentureWire.... |
| 11.03.2009 | Heart drug co. Relypsa gets $10M more to complete trials | Pharmaceutical company Relypsa announced that its investors extended its first round of funding by $10 million to a total $43 million to help it finish phase-two clinical trials on its lead drug candidate, a treatment that could alleviate s... |
| 24.02.2009 | Pearl Therapeutics gathers $8M to treat breathing disorders | Pearl Therapeutics, a Redwood City, Calif.-based developer of inhaled drugs to treat respiratory diseases like COPD and asthma, just landed $8 million in venture debt from Oxford Finance and Silicon Valley Bank to expand its product line.
T... |
| 03.02.2009 | ReShape beefs up with $20M to bust fat | ReShape Medical, maker of a non-surgical device said to treat obesity, just reeled in $20 million in second-round funding to launch a trial of its lead product. Based in San Clemente, Calif., the company’s actual technology remains fairly s... |
| 12.01.2009 | Aviir pumps in $7.8M for heart diagnostics | Stealthy biotech firm Aviir just raised a $7.8 million bridge round of financing to last it through the rest of 2009, according to VentureWire. Based in Palo Alto, Calif., the company hasn’t released much information about its actual produc... |
| 16.12.2008 | IPO market freezes out two more health care startups | Poor market conditions have dashed the IPO hopes of two more health care companies — clinical data provider Epocrates and cardiovascular drug developer Aegerion Pharmaecuticals. This makes 38 companies across all sectors that have had to pu... |
| 03.07.2008 | Pearl Therapeutics ups its first round funding | Pearl Therapeutics, a biopharmaceutical company, has upped its first round of funding to $33.5 million after an additional $18 million investment, according to VentureWire.
New investor Nektar Therapeutics joins all of the company’s previou... |
| 10.10.2007 | Life sciences briefing: Wednesday, Oct. 10, 2007 | Featured companies: 20/20 GeneSystems, Bellicum Pharmaceuticals, Cumbre Pharmaceuticals, Dara BioSciences, Enterprise Partners Venture Capital, Fermentas, International, Iasis Medical, New Leaf Venture Partners, Point Therapeutics, Power Me... |
| 05.06.2007 | Antibiotic maker BioRelix gets $26M | BioRelix, a New Haven, Conn., developer of new antibiotics, raised $25.75 million in a first funding round, VentureWire reports (subscription required). The round included New Leaf Venture Partners, Aisling Capital, CHL Medical Partners, No... |
| 21.05.2007 | Interlace Medical, women’s health company, picks up $5M | Interlace Medical, a stealthy Newton, Mass., developer of gynecological devices, raised $5 million in a first round of funding, VentureWire reports. Spray Ventures and New Leaf Venture Partners led the round. PE Wire reports that the startu... |
| 16.04.2007 | Biotech financing: Are early-stage companies hot again? | Venture investors’ interest in early-stage biotech companies may finally be starting to revive, nearly six years after the collapse of a biotech-stock bubble quashed appetites for the industry’s riskiest but often most innovative companies.... |
| 16.04.2007 | Biotech financing: Are early-stage companies hot again? | (Note: This item has been copied over to the Life Sciences page from its original location on the VentureBeat main page. To view it in its original context, with comments, click here.)
Venture investors’ interest in early-stage biotech comp... |
| 28.02.2007 |
Visiogen Raises $24M
| Irvine-based Visiogen announced Wednesday morning that it has received $24M in a venture capital round, led by CMEA Ventures. Other investors in the round included Foundation Medical Partners, Three Arch Partners, New Leaf Venture Partners,... |
| - | New York health IT accelerator is looking for applicants | New York City is growing its profile not just as a hub of healthcare IT but also as a launchpad for healthcare IT startups with the latest platform in the city, New York Digital Health Accelerator. The program is looking for 12 applicants b... |
| - | Antiviral pharma Chimerix raises $45M in series F venture round | Antiviral therapeutics company Chimerix has raised $45 million in a sixth round of financing to support two compounds in clinical trials, one of which has potential as a weapon against biological warfare.
The series F round was led by New L... |
| - | QPID Health Series B rakes in $12.3 million for surgery risk assessment platform | A pre-operative risk assessment tool developed at Massachusetts General has raised more than $12 million in a Series B round to expand its business, according to a company statement. QPID Health plans to use the new funding to double the si... |
| - | Kit Check raises $12M to boost hospital drug security tech in pharmacy, OR | A company that is using RFID technology to automate the error-prone process of manually taking inventory for drug and operating room supplies has raised $12 million in a Series B round. Kit Check‘s fundraise follows a major expansion of the... |
| - | New Leaf Venture Partners leads $10.4M Series A for RFID tagging startup Kit Check | To save time for hospital pharmacists in restocking and tracking pharmacy kits, a digital health startup is finding success using RFID tagging and looking to bring its platform into new facilities.
Kit Check just closed in on $10.4 million ... |
| - | California pharma start-up targeting COPD & asthma using inhalers raises $65M | Redwood City, California-based late-stage start-up Pearl Therapeutics has raised $65 million in a Series D funding round.
The company is developing drugs delivered through an inhaler to tackle respiratory disorders like chronic obstructive ... |
| - | Former head of Sanofi vaccines division becomes infectious disease biotech CEO | The former head of Sanofi’s (NYSE:SNY) vaccines division, one of the largest vaccine companies in the world, has joined a biotechnology company developing infectious disease vaccines as its CEO.
Wayne Pisano will lead Cranbury, New Jersey-b... |
| - | Pfizer extends Icagen offer; remains just shy of shares needed for deal | Pfizer‘s (NYSE:PFE) $56 million offer for Icagen (NASDAQ:ICGN) has been extended one more day as the pharmaceutical giant remains just shy of the minimum shares needed to execute the acquisition.
Unless there is another extension, Pfizer’s ... |
| - | Drug tracking tech developer Kit Check raises $15M in Series C round (Updated) | This post has been updated from an earlier version.
Kit Check, a company that uses RFID technology to automate the error-prone process of manually taking inventory for drug and operating room supplies, raised a $15 million Series C round. T... |
| - | Just a little overweight? Medtech company creates nonsurgical obesity treatment for weight loss | As we approach the holidays, many of us are looking at shopping catalogs, plates full of cookies and expanding waistlines. A California healthcare startup has an obesity treatment that could provide non-surgical weight loss to patients who ... |
| - | VC prediction: 2013 will be a good year for medtech deals | The combination of new CEOs at medical device firms and VC-backed companies motivated for exits will make for a lot of medtech acquisitions in 2013. Jonathan Silverstein made that prediction during a panel discussion about capitalizing in t... |
| - | Using facial recognition and AI to confirm medication adherence, AiCure raises $12.25M | AiCure, a company that combines video facial recognition and artificial intelligence to confirm that patients have taken their medication has raised a $12.25 million Series A round, according to a company statement. The fundraise underscore... |
| - | iRhythm raises $16M for patch that stores heartbeat data to help spot arrhythmia | A patch that acts as an electrocardiogram to record and store heartbeats for up to 14 days so it can be analyzed later for signs of arrhythmia has raised $16 million in a series D round. The cardiac rhythm diagnostics device is designed to ... |
| - | Kaiser Permanente Ventures senior managing director talks about his return (Q&A) | Sam Brasch has moved back to Kaiser Permanente Ventures, the investment arm of the Kaiser Permanente health system, this time as senior managing director. The move comes after a year of working with New Leaf Venture Partners, which invests ... |
| - | It looks like UnitedHealth is acquiring Audax Health Solutions | UnitedHealth Group (NYSE: UNH) is poised to acquire digital health company Audax Health Solutions according to a filing with the Federal Trade Commission. The move reflects a growing priority among payers to develop and add tools to boost m... |
| - | Digital health group with patient engagement focus attracts funding from Florida insurer, Facebook VP | A subsidiary of Florida’s largest insurer led a series B round for a digital health group that uses a selection of patient engagement tools to improve outcomes.
Audax Health Solutions raised $20 million in a round led by Navigy Holdings, a ... |
| - | Deciphera raises $75M directed toward kinase-inhibiting cancer drug | Waltham, Massachusetts-based Deciphera has now raised $75 million with funding led by New Leaf Ventures, which was joined by the company’s lone major longtime backer, an unnamed “high net worth” investor, according to Xconomy. The funding w... |
| - | Fundraising: Abdominal aortic aneurysm repair company raises $6 million | Company name: Altura Medical.
Industry: Medical devices.
Location: San Clemente, California.
Product: Abdominal Aortic Aneurysm Stent-Graft to repair abdominal aortic aneurysms.
Money raised: $6 million (earlier regulatory filings show the ... |
| - | Pfizer-Icagen deal faces problem: Merlin Nexus opposes price | Pfizer’s (NYSE:PFE) $56 million bid to acquire Icagen (NASDAQ:ICGN) faces a big hurdle — two of Icagen’s largest shareholders.
Merlin Nexus and New Leaf Venture Partners, two firms holding Icagen stock, submitted a July 28 letter to the Ica... |
| - | Investors blocking PFE’s $56M ICGN bid say firm’s value could be $165M | Two Icagen (NASDAQ:ICGN) institutional investors opposed to Pfizer‘s (NYSE:PFE) $56 million offer for the pain drug development company now say the company’s value should be nearly three times that amount.
Merlin Nexus and New Leaf Venture ... |
| - | Buoyed by mobile health trends, TigerText raises $21M in Series B round | One significant area of health IT growth has been companies that have responded to the dual need for improving communication between medical staff to reduce errors and duplicated tests and the security challenges the growing Bring Your Own ... |
